LONA - Athira Pharma, Inc.
5.3
-0.070 -1.321%
Share volume: 12,517
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$5.37
-0.07
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-01-2024 | 11-07-2024 | 02-27-2025 | 05-09-2025 | 11-06-2025 | |
| Cash flow financing | 0.000 | 148.000 K | 12.000 K | 34.000 K | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -12.763 M | 4.380 M | -4.972 M | -28.791 M | -22.016 M | 0.000 | |
| Net income | -26.337 M | -26.859 M | -28.741 M | -15.003 M | -9.143 M | -6.611 M | |
| Depreciation | 242.000 K | 242.000 K | 243.000 K | 243.000 K | 243.000 K | 243.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 13.041 M | 26.562 M | 18.039 M | -2.812 M | -7.351 M | 5.654 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 5.000 K | 28.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -12.763 M | 4.380 M | -4.972 M | -28.791 M | -22.016 M | 986.000 K |